Marije Risselada

Marije Risselada

Auto-generated profile, based on publicly available information

Marije Risselada

Department of Veterinary Clinical Sciences Purdue University West Lafayette Indiana USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Veterinary Clinics of North America: Small Animal Practice
Verified
Journal Article
Closed access
MRMarije Risselada
Marije Risselada

1 March 2024 in American Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
MBMiriam G. Bates
Miriam G. Bates
MRMarije Risselada
Marije Risselada
DPDaniela C. Peña-Hernandez
Daniela C. Peña-Hernandez
KHKenitra Hendrix
Kenitra Hendrix
GMGeorge E. Moore
George E. Moore
OBJECTIVE: To establish the lowest effective dose of commercially available nanoparticulate silver (AgNP) for antibacterial activity against Escherichia coli (E coli) and methicillin-resistant Staphylococcus pseudintermedius (MRSP), in vitro, and to establish the effect of incorporating AgNP into carriers for sustained release on this antibacterial activity. SAMPLES: Silver nanoparticle dispersion (0.02 mg/mL) composed of citrate-stabilized, spherical, 10 nm diameter nanoparticles in aqueous buffer. PROCEDURES: E coli and MRSP were treated with 0.01 mg/mL AgNP. The highest concentration of bacteria where growth was inhibited by AgNP was selected for treatment with 0.01 mg/mL AgNP incorporated 3 carriers for sustained release: calcium sulfate hemihydrate (CSH) beads, poloxamer 407 gel, and gelatin sponge, respectively. The antibacterial activity of AgNP and AgNP incorporated into carriers for sustained release was compared with a mixed linear effects model. RESULTS: AgNP inhibited bacterial growth at a concentration of 101 for MRSP and 103 for E coli. For MRSP, the treatment group was associated with bacterial growth (P < .001) while the concentration of bacteria and time were not (P = .292 and P = .289, respectively). For E coli, the treatment group and concentration of bacteria were associated with bacterial growth (P < .001 and = .029, respectively) while time was not (P = .095). Poloxamer 407 gel exerted standalone antibacterial activity against both species of bacteria; sponge and CSH beads did not. CLINICAL RELEVANCE: AgNP has antibacterial activity against E coli and MRSP, which can be reduced when incorporated into carriers for sustained release. Poloxamer 407 gel alone and combined with AgNP exerts antibacterial activity against E coli and MRSP.

18 February 2023 in Veterinary Surgery
Verified
Journal Article
Open access
MSMichele A. Steffey
Michele A. Steffey
MRMarije Risselada
Marije Risselada
VSValery F. Scharf
Valery F. Scharf
Nicole J. BuoteNicole J. Buote
Nicole J. Buote
HZHelia Zamprogno
Helia Zamprogno
DGDominique Griffon
Dominique Griffon
Objective: This review discusses the scientific evidence regarding effects of insufficient rest on clinical performance and house officer training programs, the associations of clinical duty scheduling with insufficient rest, and the implications for risk management.Study design: Narrative review.Methods: Several literature searches using broad terms such as “sleep deprivation,” “veterinary,” “physician,” and “surgeon” were performed using PubMed and Google scholar.Results: Sleep deprivation and insufficient rest have clear and deleterious effects on job performance, which in healthcare occupations impacts patient safety and practice function. The unique requirements of a career in veterinary surgery, which may include on‐call shifts and overnight work, can lead to distinct sleep challenges and chronic insufficient rest with resultant serious but often poorly recognized impacts. These effects negatively impact practices, teams, surgeons, and patients. The self‐assessment of fatigue and performance effect is demonstrably untrustworthy, reinforcing the need for institution‐level protections. While the issues are complex and there is no one‐size‐fits‐all approach, duty hour or workload restrictions may be an important first step in addressing these issues within veterinary surgery, as it has been in human medicine.Conclusion: Systematic re‐examination of cultural expectations and practice logistics are needed if improvement in working hours, clinician well‐being, productivity, and patient safety are to occur.Clinical significance (or Impact): A more comprehensive understanding of the magnitude and consequence of sleep‐related impairment better enables surgeons and hospital management to address systemic challenges in veterinary practice and training programs.

1 April 2021 in Veterinary Surgery
Verified
Journal Article
Closed access
PDF file
APAllison B. Putterman
Allison B. Putterman
LSLaura E. Selmic
Laura E. Selmic
CKCameron Kindra
Cameron Kindra
DDDaniel J. Duffy
Daniel J. Duffy
MRMarije Risselada
Marije Risselada
HPHeidi Phillips
Heidi Phillips

14 May 2016 in Veterinary Surgery
Verified
Journal Article
Closed access
PDF file
MRMarije Risselada
Marije Risselada
KMKyle G Mathews
Kyle G Mathews
EGEmily Griffith
Emily Griffith

5 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MRMarije Risselada
Marije Risselada
KLKeith E. Linder
Keith E. Linder
EGEmily Griffith
Emily Griffith
BRBrittney V. Roberts
Brittney V. Roberts
GDGigi Davidson
Gigi Davidson
KMKristen M. Messenger
Kristen M. Messenger
The objectives of this study were to assess the pharmacokinetics and safety of subcutaneously delivered carboplatin in poloxamer 407 in rats. Carboplatin (5mg/rat) in 0.5ml poloxamer 407 (1.0 ml total volume) was administered subcutaneously in a right subcutaneous perineal incision in all 12 treatment rats. Three control rats received 1.0 ml of poloxamer 407. Total platinum was measured in plasma q24hrs from 0 to 168hrs. Protein-unbound platinum was measured in plasma at 168hrs. After sacrifice on day 7, total platinum was determined in wound bed muscle. Platinum concentrations in all samples were measured by ICP-MS. Wounds were visually assessed daily for 7 days. Perineal tissues (full wound bed including muscle, subcutis, skin) were assessed histologically and scored. Total platinum was detectable in plasma from 24 to 168 hrs. Total plasma platinum AUC and Cmax were 9,165.3 ng/mL•h and 129.4 ng/mL. Day 7 total platinum concentration in muscle was approximately 10-fold higher than total plasma platinum concentration. No unbound platinum was detected in plasma samples at 168 hours. No wound healing complications were detected at any time point, nor was tissue necrosis observed histologically. The results of this study suggest that subcutaneous carboplatin in poloxamer 407 can be used in vivo providing direct tissue exposure to carboplatin without significant local effects or systemic absorption and without wound healing complications.